Behavioral aspects of weight loss in type 2 diabetes

Current Diabetes Reports

Volumn 8, Issue 2, 2008, Pages 126-131

  Wing, Rena R ^a   Marquez, Becky ^b  

^a MIRIAM HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; METFORMIN; PLACEBO;

BEHAVIOR CHANGE; BLOOD PRESSURE REGULATION; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIETARY FIBER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; MORBIDITY; MORTALITY; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; EXERCISE; FEMALE; MALE; PSYCHOLOGICAL ASPECT;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; MALE; RISK FACTORS; WEIGHT LOSS;

EID: 44849114356     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-008-0023-0     Document Type: Review

References (23)

1. Wing RR: Behavioral approaches to the treatment of obesity. In Handbook of Obesity. Edited by Bray GA, Bouchard C, James WPT. New York: Marcel Dekker, Inc.; 1998:855-873.
2. Tuomilehto J, Lindstrom J, Eriksson J, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
4. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al.: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679.
5. Wing RR, Hamman RF, Bray GA, et al.: Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 2004, 12:1426-1434.
6. Hamman RF, Wing RR, Edelstein SL, et al.: Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006, 29:2102-2107.
7. Punzalan C, Paxton KC, Guentzel H, et al.: Seeking community input to improve implementation of a lifestyle modification program. Ethn Dis 2006, 16(1 Suppl 1): S79-S88.
8. Ackermann RT, Marrero DG: Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ 2007, 33:69, 74-75, 77-78.
9. Absetz P, Valve R, Oldenburg B, et al.: Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial. Diabetes Care 2007, 30:2465-2470.
10. Cramer JS, Sibley RF, Bartlett DP, et al.: An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes. Diabetes Educ 2007, 33:503-508.
11. Wing RR: Weight loss in the management of type 2 diabetes. In Evidence-Based Diabetes Care, Edited by Gerstein HHR. Hamilton, Ontario, Canada: Decker, Inc.; 2001:252-276.
12. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health [no authors listed]. Obes Res 1998, 6(Suppl 2): 51S-210S.
13. West DS, DiLillo V, Bursac Z, et al.: Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007, 30:1081-1087.
14. Lean ME, Powrie JK, Anderson AS, et al.: Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990, 7:228-233.
15. Williamson DF, Thompson TJ, Thun M, et al.: Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000, 23:1499-1504.
16. Bloom E, MacLean C, Reed D, Yano K: Paradoxical impact of weight change on coronary heart disease risk factors and risk of coronary heart disease [abstract]. South Carolina CVD Epidemiology Newsletter 1987, 41:117.
17. Hanson RL, McCance DR, Jacobsson LT, et al.: The U-shaped association between body mass index and mortality: relationship with weight gain in a Native American population. J Clin Epidemiol 1995, 48:903-916.
18. Chaturvedi N, Fuller JH: Mortality risk by body weight and weight change in people with NIDDM: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1995, 18:766-774.
19. Gregg EW, Gerzoff RB, Thompson TJ, et al.: Trying to lose weight, losing weight, and 9-year mortality in overweight U.S. adults with diabetes. Diabetes Care 2004, 27:657-662.
20. Eilat-Adar S, Eldar M, Goldbourt U: Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol 2005, 161:352-358.
21. Ryan DH, Espeland MA, Foster GD, et al.: Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003, 24:610-628.
22. Look AHEAD Research Group: The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) 2006, 14:737-752.
23. Look AHEAD Research Group: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007, 30:1374-1383.